The knockdown of CD44 or ALK4 with specific shRNAs largely eliminated the tumor growth in immunodeficient xenogenic hosts, indicated that signals through CD44 and ALK4 are interrelated and critical for tumor growth in vivo. The gene discussed is ACVR1B; the disease is neoplasm.